Movement Disorders Center, Department of Neurology, School of Medicine, University of São Paulo, São Paulo, Brazil; Transcranial Magnetic Stimulation Laboratories, Psychiatry Institute, University of São Paulo, São Paulo, Brazil.
Transcranial Magnetic Stimulation Laboratories, Psychiatry Institute, University of São Paulo, São Paulo, Brazil; Pain Center, Department of Neurology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Brain Stimul. 2018 Mar-Apr;11(2):249-260. doi: 10.1016/j.brs.2017.11.015. Epub 2017 Nov 23.
The cerebellum is involved in the pathophysiology of many movement disorders and its importance in the field of neuromodulation is growing.
To review the current evidence for cerebellar modulation in movement disorders and its safety profile.
Eligible studies were identified after a systematic literature review of the effects of cerebellar modulation in cerebellar ataxia, Parkinson's disease (PD), essential tremor (ET), dystonia and progressive supranuclear palsy (PSP). Neuromodulation techniques included transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and deep brain stimulation (DBS). The changes in motor scores and the incidence of adverse events after the stimulation were reviewed.
Thirty-four studies were included in the systematic review, comprising 431 patients. The evaluation after stimulation ranged from immediately after to 12 months after. Neuromodulation techniques improved cerebellar ataxia due to vascular or degenerative etiologies (TMS, tDCS and DBS), dyskinesias in PD patients (TMS), gross upper limb movement in PD patients (tDCS), tremor in ET (TMS and tDCS), cervical dystonia (TMS and tDCS) and dysarthria in PSP patients (TMS). All the neuromodulation techniques were safe, since only three studies reported the existence of side effects (slight headache after TMS, local skin erythema after tDCS and infectious complication after DBS). Eleven studies did not mention if adverse events occurred.
Cerebellar modulation can improve specific symptoms in some movement disorders and is a safe and well-tolerated procedure. Further studies are needed to lay the groundwork for new researches in this promising target.
小脑参与许多运动障碍的病理生理学过程,其在神经调节领域的重要性日益增加。
综述小脑调节在运动障碍中的作用及其安全性。
通过系统文献复习,评估小脑调节在小脑性共济失调、帕金森病(PD)、特发性震颤(ET)、肌张力障碍和进行性核上性麻痹(PSP)中的作用,确定纳入研究。神经调节技术包括经颅磁刺激(TMS)、经颅直流电刺激(tDCS)和深部脑刺激(DBS)。回顾刺激后运动评分的变化和不良事件的发生率。
系统综述共纳入 34 项研究,包括 431 例患者。刺激后评估时间从即刻至 12 个月不等。神经调节技术可改善血管性或退行性病因引起的小脑共济失调(TMS、tDCS 和 DBS)、PD 患者的运动障碍(TMS)、PD 患者的上肢粗大运动(tDCS)、ET 震颤(TMS 和 tDCS)、颈肌张力障碍(TMS 和 tDCS)和 PSP 患者的构音障碍(TMS)。所有神经调节技术均安全,仅 3 项研究报道存在副作用(TMS 后轻度头痛、tDCS 后局部皮肤红斑、DBS 后感染并发症)。11 项研究未提及是否发生不良事件。
小脑调节可改善某些运动障碍的特定症状,是一种安全且耐受良好的方法。需要进一步研究为这一有前途的治疗靶点的新研究奠定基础。